Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: impact on diagnostic confidence and diagnostic accuracy

BACKGROUND: The development of diagnostic tools capable of accurately identifying the pathophysiology of mild cognitive impairment (MCI) has become a crucial target considering the claim that disease-modifying treatments should be administered as early as possible in the disease course. Transcranial...

Descripción completa

Detalles Bibliográficos
Autores principales: Padovani, Alessandro, Benussi, Alberto, Cotelli, Maria Sofia, Ferrari, Clarissa, Cantoni, Valentina, Dell’Era, Valentina, Turrone, Rosanna, Paghera, Barbara, Borroni, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886207/
https://www.ncbi.nlm.nih.gov/pubmed/31787103
http://dx.doi.org/10.1186/s13195-019-0555-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886207/
https://www.ncbi.nlm.nih.gov/pubmed/31787103
http://dx.doi.org/10.1186/s13195-019-0555-3

Ejemplares similares